|
PWP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.489600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.389200E-01 |
| Normal-vs-Stage2 |
6.072800E-01 |
| Normal-vs-Stage3 |
3.148200E-02 |
| Normal-vs-Stage4 |
6.958000E-01 |
| Stage1-vs-Stage2 |
5.934800E-01 |
| Stage1-vs-Stage3 |
1.850340E-02 |
| Stage1-vs-Stage4 |
7.649000E-01 |
| Stage2-vs-Stage3 |
2.910400E-02 |
| Stage2-vs-Stage4 |
4.987200E-01 |
| Stage3-vs-Stage4 |
2.954600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.000200E-01 |
| Normal-vs-AfricanAmerican |
3.507400E-01 |
| Normal-vs-Asian |
4.976000E-01 |
| Caucasian-vs-AfricanAmerican |
7.489200E-01 |
| Caucasian-vs-Asian |
4.548800E-01 |
| AfricanAmerican-vs-Asian |
5.174800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.217000E-01 |
| Normal-vs-Female |
7.264300E-03 |
| Male-vs-Female |
6.801600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.038400E-01 |
| Normal-vs-Extreme_Weight |
3.714400E-01 |
| Normal-vs-Obese |
2.256800E-01 |
| Normal-vs-Extreme_Obese |
2.304200E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.033000E-01 |
| Normal_Weight-vs-Obese |
6.998600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.259500E-02 |
| Extreme_Weight-vs-Obese |
8.675500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.650400E-02 |
| Obese-vs-Extreme_Obese |
3.902300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.425700E-02 |
| Normal-vs-Age(41-60Yrs) |
6.876200E-02 |
| Normal-vs-Age(61-80Yrs) |
7.388000E-01 |
| Normal-vs-Age(81-100Yrs) |
6.515400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.103900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.318160E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.712300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.820400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.563600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.169400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.224000E-01 |
| Normal-VS-Type2 PRCC |
2.960600E-01 |
| Normal-VS-KIRP CIMP |
2.980400E-01 |
| Normal-VS-Unclassified PRCC |
2.636000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.924800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.507000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.874200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.992000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.191000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.910600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.043800E-01 |
| Normal-vs-N1 |
1.264010E-02 |
| Normal-vs-N2 |
8.943800E-01 |
| N0-vs-N1 |
8.018300E-03 |
| N0-vs-N2 |
8.832600E-01 |
| N1-vs-N2 |
2.653000E-01 |
|
|
